Astec Life Sciences Limited has announced the closure of its trading window for dealing in the company's securities. This closure will be effective from Thursday, January 1st, 2026. The trading window will remain shut until 48 hours after the declaration of the unaudited financial results for the quarter and nine months ending on December 31st, 2025. All officers and designated employees, including directors and auditors, have been informed not to engage in any trading activities such as buying, selling, gifting, pledging, or unpledging of the company's equity shares during this period. This measure is in accordance with the Company's Code of Conduct for Prohibition of Insider Trading, aligned with SEBI (Prohibition of Insider Trading) Regulations, 2015.